Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Invested Capital (2023 - 2026)

TriSalus Life Sciences has reported Return on Invested Capital over the past 4 years, most recently at 0.01% for Q1 2026.

  • For Q1 2026, Return on Invested Capital fell 11.0% year-over-year to 0.01%; the TTM value through Mar 2026 reached 0.01%, down 11.0%, while the annual FY2025 figure was 0.12%, 9.0% up from the prior year.
  • Return on Invested Capital for Q1 2026 was 0.01% at TriSalus Life Sciences, up from 0.1% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.31% in Q3 2024 and troughed at 0.1% in Q4 2025.
  • A 4-year average of 0.05% and a median of 0.01% in 2023 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: surged 31bps in 2024 and later tumbled -39bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.06% in 2023, then soared by 386bps to 0.28% in 2024, then tumbled by -137bps to 0.1% in 2025, then skyrocketed by 88bps to 0.01% in 2026.
  • Business Quant data shows Return on Invested Capital for TLSI at 0.01% in Q1 2026, 0.1% in Q4 2025, and 0.03% in Q3 2025.